関連する実験動画
Updated: Sep 9, 2025

08:49
Models of Bone Metastasis
Published on: September 4, 2012
42.3K
骨転移患者における癌および非癌死亡率の包括的な分析:集団ベースの研究
Xia Yan1, Hongyu Liu2, Xueqi Bai1
1Cancer Center, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Journal of bone oncology
|September 2, 2025
まとめ
骨転移の患者では 非癌による死亡が増加しており 生存率に影響しています 感染と心血管疾患の標的型予防戦略の必要性を強調しています
科学分野:
- 腫瘍学
- 公衆衛生
- 流行病学
背景:
- 骨転移はがん治療における大きな課題であり,患者の予後と生活の質に影響を及ぼします.
- 死亡原因の全スペクトルを理解することは 総合的な生存計画に不可欠です
研究 の 目的:
- 骨転移と診断された患者の死因を特徴づける.
- この患者グループにおけるデータ主導の生存計画と臨床意思決定の情報提供.
主な方法:
- 2010年から2021年までの監視,疫学,最終結果 (SEER) レジストリからのデータを使用した.
- 新たに診断された骨転移の186,404人の患者を特定した.
- 死亡の原因は,癌特異的,非癌,または癌の後の死亡因子として分類され,過剰な非癌死亡率の標準死亡率 (SMR) を計算します.
主要な成果:
- 71. 5% の患者の主な死因は癌でした.
- 非癌の原因は5.9%を占め,2010年の6.3%から2021年の9.5%に増加した.
- 常見の非癌の原因には,心血管疾患,COPD,脳血管疾患が含まれており,HIV関連感染症,結血病,自殺,肺炎/インフルエンザによる死亡率が顕著である.
結論:
- 癌以外の死亡率は,骨転移の患者で懸念が高まっています.
- 感染,心血管疾患,その他の予防可能な原因に対処する標的型予防介入が不可欠です.
さらに関連する動画
関連する概念動画
Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
Comparing the Survival Analysis of Two or More Groups
280
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
280
Kaplan-Meier Approach
258
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
258
Metastasis
5.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K

